+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor

A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor

Addiction 112(6): 1025-1035

We tested the efficacy of daily contingent reinforcement for reducing alcohol use compared with (yoked) non-contingent reinforcement (NR) using a transdermal alcohol sensor to detect alcohol use. Pilot randomized controlled design with 1 baseline week, 3 intervention weeks and 1-month follow-up. New England, USA. Heavy drinking adults (46.7% female) not seeking treatment were randomized to (1) an escalating schedule of cash reinforcement (CR; n = 15) for days on which alcohol was neither reported nor detected or (2) yoked NR (n = 15). Reinforcement for CR participants started at $5 and increased $2 every subsequent day on which alcohol was not detected or reported, to a maximum of $17. Participants received no reinforcement for days on which alcohol use was detected or reported, and the reinforcer value was re-set to $5 the day after a drinking day. NR participants were yoked to the daily reinforcer value of an individual in the CR condition, in order of enrollment. Paired participants in CR and NR therefore received the same amount of money, but the amount for the NR participant was not behavior-related. The primary outcome was percentage of days without sensor-detected drinking. Secondary outcomes were number of consecutive days with no detected drinking, peak transdermal alcohol concentration (TAC), self-reported drinks per week and drinking below NIH low-risk guidelines. Controlling for baseline, CR had a higher percentage of days with no drinking detected (54.3%) than NR (31.2%) during intervention weeks [P = 0.05, Cohen's d = 0.74; 95% confidence interval (CI) = 0.007-1.47]. The longest period of consecutive days with no drinking detected was 8.0 for CR versus 2.9 for NR (P = 0.03, d = 0.85; 95% CI = 0.08-1.61). Peak TAC during intervention showed a non-significant group difference (P = 0.20; d = 0.48; 95% CI = 0.00-1.18); a similar result was found for drinks per week (P = 0.12; d = 0.59; 95% CI = 0.00-1.30). Four times more participants in CR drank below NIH low-risk drinking guidelines during intervention than did participants in NR: 31.1 versus 7.1% (P = 0.07; d = 0.71; 95% CI = -0.04 to 1.46). At 1-month follow-up, the highest number of consecutive days without drinking (self-report) did not differ significantly between conditions (P = 0.26), but showed a medium effect size (d = 0.44; 95% CI = -0.32 to 1.18). Cash incentives linked to a transdermal alcohol sensor can reduce heavy alcohol consumption while the incentives are in operation.

(PDF emailed within 0-6 h: $19.90)

Accession: 059391476

Download citation: RISBibTeXText

PMID: 28107772

DOI: 10.1111/add.13767

Related references

Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug and Alcohol Dependence 118(2-3): 391-399, 2012

Transdermal alcohol monitoring combined with contingency management for driving while impaired offenders: A pilot randomized controlled study. Traffic Injury Prevention 19(5): 455-461, 2018

Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management. Behavioural Pharmacology 29(5): 462-468, 2018

A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness. American Journal of Psychiatry 174(4): 370-377, 2017

Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. Drug and Alcohol Dependence 142: 301-306, 2015

Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder. International Journal on Drug Policy 67: 24-33, 2019

Alcohol-Adapted Anger Management Treatment: A Randomized Controlled Trial of an Innovative Therapy for Alcohol Dependence. Journal of Substance Abuse Treatment 59: 83-93, 2016

Brief alcohol intervention and alcohol assessment do not influence alcohol use in injured patients treated in the emergency department: a randomized controlled clinical trial. Addiction 102(8): 1224-1233, 2007

A Randomized Trial of Contingency Management for Smoking Cessation During Intensive Outpatient Alcohol Treatment. Journal of Substance Abuse Treatment 72: 89-96, 2016

Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. Southern Medical Journal 84(3): 312-321, 1991

A randomized controlled trial of contingency management for smoking abstinence versus contingency management for shaping cessation: One-year outcome. Experimental and Clinical Psychopharmacology 2019, 2019

Promoting Alcohol Reduction in Non-Treatment Seeking parents (PAReNTS): a protocol for a pilot feasibility cluster randomised controlled trial of alcohol screening and brief interventions to reduce parental alcohol use disorders in vulnerable families. Pilot and Feasibility Studies 4: 111, 2018

Translating transdermal alcohol monitoring procedures for contingency management among adults recently arrested for DWI. Addictive Behaviors 83: 56-63, 2018

Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial. Journal of the International Association of Providers of Aids Care 16(3): 276-285, 2016

Assessment reactivity: A randomized controlled trial of alcohol-specific measures on alcohol-related behaviors. Addictive Behaviors 67: 44-48, 2016